265 related articles for article (PubMed ID: 21149386)
1. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
[TBL] [Abstract][Full Text] [Related]
2. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
Fan Y; Garcia-Rodriguez C; Lou J; Wen W; Conrad F; Zhai W; Smith TJ; Smith LA; Marks JD
PLoS One; 2017; 12(3):e0174187. PubMed ID: 28323873
[TBL] [Abstract][Full Text] [Related]
3. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
[TBL] [Abstract][Full Text] [Related]
4. Potent neutralization of botulinum neurotoxin/B by synergistic action of antibodies recognizing protein and ganglioside receptor binding domain.
Chen C; Wang S; Wang H; Mao X; Zhang T; Ji G; Shi X; Xia T; Lu W; Zhang D; Dai J; Guo Y
PLoS One; 2012; 7(8):e43845. PubMed ID: 22952786
[TBL] [Abstract][Full Text] [Related]
5. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
[TBL] [Abstract][Full Text] [Related]
6. A Four-Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotypes C and D.
Garcia-Rodriguez C; Yan S; Geren IN; Knopp KA; Dong J; Sun Z; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564645
[TBL] [Abstract][Full Text] [Related]
7. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.
Garcia-Rodriguez C; Razai A; Geren IN; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29494481
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
[TBL] [Abstract][Full Text] [Related]
9. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
10. Extraction of BoNT/A, /B, /E, and /F with a single, high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS.
Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
PLoS One; 2010 Aug; 5(8):e12237. PubMed ID: 20808925
[TBL] [Abstract][Full Text] [Related]
11. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells.
Lam KH; Perry K; Shoemaker CB; Jin R
Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32992561
[TBL] [Abstract][Full Text] [Related]
12. In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).
Bakherad H; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Mohammadi M; Ebrahimizadeh W; Safaee Ardakani L; Zare H
Mol Biotechnol; 2013 Oct; 55(2):159-67. PubMed ID: 23666874
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E.
Baldwin MR; Tepp WH; Pier CL; Bradshaw M; Ho M; Wilson BA; Fritz RB; Johnson EA; Barbieri JT
Infect Immun; 2005 Oct; 73(10):6998-7005. PubMed ID: 16177380
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a neutralizing monoclonal antibody against botulinum neurotoxin serotype F, following vaccination with active toxin.
Brown DR; Lloyd JP; Schmidt JJ
Hybridoma; 1997 Oct; 16(5):447-56. PubMed ID: 9388028
[TBL] [Abstract][Full Text] [Related]
15. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
[TBL] [Abstract][Full Text] [Related]
16. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
[TBL] [Abstract][Full Text] [Related]
17. Multicolor fluorescence activated cell sorting to generate humanized monoclonal antibody binding seven subtypes of BoNT/F.
Fan Y; Sun Z; Conrad F; Wen W; Zhao L; Lou J; Zhou Y; Farr-Jones S; Marks JD
PLoS One; 2022; 17(9):e0273512. PubMed ID: 36048906
[TBL] [Abstract][Full Text] [Related]
18. Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating.
Lou J; Geren I; Garcia-Rodriguez C; Forsyth CM; Wen W; Knopp K; Brown J; Smith T; Smith LA; Marks JD
Protein Eng Des Sel; 2010 Apr; 23(4):311-9. PubMed ID: 20156888
[TBL] [Abstract][Full Text] [Related]
19. Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
Scotcher MC; McGarvey JA; Johnson EA; Stanker LH
PLoS One; 2009; 4(3):e4924. PubMed ID: 19290051
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.
Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]